TORONTO -- (MARKET WIRE) -- September 27, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that Torc Investments and Research LLC, a NASD registered broker-dealer, initiated research coverage of the Company today with a Buy rating and a 12-month price target of $3-$3.50.
